Diabetes (EASD) e la European Society of Cardiology (ESC) Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Malattie cardiovascolari e diabete in soggetti con malattia mentale grave: Position Paper della European Psychiatric Association (EPA), in collaborazione con la European Association for the Study of

M. De Hert1, J.M. Dekker2, D. Wood3, K.G. Kahl4, R.I.G. Holt5, H.-J. Möller6

1 University Psychiatric Centre Catholic University Leuven Campus Kortenberg, Kortenberg, Belgium; 2 Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands; 3 National Heart and Lung Institute Cardiovascular Science, Imperial College, Charing Cross Campus, London, United Kingdom; 4 Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany; 5 Endocrinology & Metabolism, Developmental Origins of Health and Disease, School of Medicine, University of Southampton, Southampton, United Kingdom; 6 Department of Psychiatry Ludwig-Maximilians- University, Munich, Germany

People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension, and dyslipidaemia (Table I). Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors (Table II). Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate co-operation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes.

Scarica il PDF